The Price of Unquestioning Allegiance Heidi Overton’s confirmation hearing for the Food and Drug Administration top job was not merely a domestic political skirmish; it was a stark demonstration of how deeply scientific institutions Read More
Beyond the Rhetoric: Weaponizing Regulators Former President Donald Trump’s recent demand for the Federal Communications Commission (FCC) to “punish or rebuke” an NBC journalist reveals far more than another frustrated politician railing against perceived Read More
When President Trump unexpectedly dialed into a NASA press conference this Sunday, it wasn’t merely an unusual interruption; it was a potent, if subtle, statement about where the lines of scientific institutional autonomy and Read More
President Trump’s recent executive order, aimed at establishing a commission to create a “US Space Academy” under NASA’s jurisdiction, presents a fascinating case study in policy announcement versus strategic clarity. While framed as Read More
The Exception, Not the Rule: Why Panic’s Transparency Matters Panic is refunding customers for an illegal 19 percent tariff levied on its yellow Playdate handheld. This isn’t just a story about a small indie Read More
Beyond the Numbers: A Failure of Platform Governance The Centers for Disease Control and Prevention’s latest data, indicating a persistent decline in US kindergarten vaccination rates, reads less as a public health statistic and Read More
The Analogue Underbelly of Digital Commerce A diarrheal parasite has sickened over 24,000 people and claimed two lives this summer, and the subsequent outrage has, predictably, fixated on political malfeasance. While Senator Elizabeth Warren rightly interrogates Read More
The idea that political discourse, specifically the pronouncements of a former President, can be packaged and sold as a high-speed data feed for financial gain marks a disturbing escalation in the commodification of public life. Read More
The Price of Populist Politics on Public Health Infrastructure The swift condemnation of a political order demanding pharmaceutical companies split the Measles, Mumps, and Rubella (MMR) vaccine into individual doses reveals a deeper fault line Read More
The Policy Pivot, From Algorithm to Oval Office Eighteen becomes eleven. Not a subtle shift in a budgeting document, but a stark, unilateral re-engineering of federal vaccine recommendations for children, signed into executive order. President Read More